Within a horizontal differentiation model and allowing for heterogeneous qualities, we
analyze the effects of reference pricing reimbursement on firms' pricing strategies. With this …

Objetivos: Describir políticas alternativas para el fomento de la competencia en precios en
el mercado de medicamentos genéricos de países altamente regulados, y presentar …

En los últimos años, este activismo se ha concretado en la decisión de la Comisión Europea
sobre ASPEN PHARMACEUTICAL, un precedente muy relevante de prohibición y sanción …

Background: In many countries with generic reference pricing, generic producers and
distributors compete by means of undisclosed discounts offered to pharmacies in order to …

This paper surveys the literature on price regulation in the pharmaceutical sector. After
summarizing the well-known results of the available literature, the paper focuses on …

This paper examines competition between generic and brand-name drugs in the regulated
Spanish pharmaceutical market. A nested logit demand model is specified for the three most …

This paper examines statins competition in the Spanish pharmaceutical market, where
prices are highly regulated, and simulates a situation in which there is unrestricted price …

Although economic theory indicates that it should not be necessary to intervene in the
generic drug market through price regulation, most European Union (EU) countries …

En este capítulo se revisa la literatura existente sobre la regulación de precios en el sector
farmacéutico. Tras resumir los resultados bien conocidos que constan en la literatura …

This paper examines competition between generic and brand-name drugs in the regulated
Spanish pharmaceutical market. A nested logit demand model is specified for the three most …